Suzhou Bright Scistar Biotechnology Company Ltd. is located in Med Park, Science and Technology Town, Suzhou New District. It was founded in May, 2013, and is a key science and technology institute of Suzhou New District. The company is based on Soochow University-Bright Scistar.....
Soochow University-Bright Scistar Antibody Engineering Joint Laboratory was established in September, 2014. Zhang Xueguang, Director of Jiangsu Provincial Institute of Clinical Immunology and Institute of Biology and Medical Sciences......
We set our feet in inmunology field and focuses on the reserch of relative biologics of costimulatory molecule, an important target in immunologic diagnosis and treatment. Our services mainly include research, production, and sale of antibodies, kits, In Vitro diagnostics reagents and potential therapeutic antibody medicines.
Report news of the company in first time, promote enterprise culture and merit, and build a bridge for the development of culture and communication of opinions.
Talents are the top resources of Bright Scistar Biotechnology Company Ltd., which stick to the “people foremost” management philosophy and regard talents as the base for entrepreneurship, competition and development.
Bright Scistar holds “quality of gold, bliss for humankind” as its aim, “innovation makes future” as its developing philosophy, “honest and steady management” as its developing strategy, “pragmatic and honest, strive to be the best” as its merit. We set our feet in inmunology.....
Suzhou
Bright Scistar Biotechnology Company Ltd. is located in Med Park, Science and
Technology Town, Suzhou New District. It was founded in May, 2013, and is a key
science and technology institute of Suzhou New District. The company is based
on Soochow
University-Bright Scistar Antibody Engineering Joint Laboratory, and integrates
resources of national and international universities, enterprises and
institutes, collaboratively penetrated hard technological targets in the
process of antibody research, development and industrialization, and finally
establishes a hatching system for technology innovation by basing on the
company, aiming at the market, and combining production, academics and
researches, then enters the market with iconic antibody products.